Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-25-007109
Filing Date
2025-05-09
Accepted
2025-05-09 11:28:32
Documents
81
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q dwtx-20250331x10q.htm   iXBRL 10-Q 1210672
2 EX-3.2 dwtx-20250331xex3d2.htm EX-3.2 106195
3 EX-31.1 dwtx-20250331xex31d1.htm EX-31.1 12214
4 EX-31.2 dwtx-20250331xex31d2.htm EX-31.2 12096
5 EX-32.1 dwtx-20250331xex32d1.htm EX-32.1 6784
6 EX-32.2 dwtx-20250331xex32d2.htm EX-32.2 6791
7 EX-99.1 dwtx-20250331xex99d1.htm EX-99.1 54981
8 GRAPHIC dwtx-20250331x10q006.jpg GRAPHIC 56189
  Complete submission text file 0001558370-25-007109.txt   7050746

Data Files

Seq Description Document Type Size
9 EX-101.SCH dwtx-20250331.xsd EX-101.SCH 49013
10 EX-101.CAL dwtx-20250331_cal.xml EX-101.CAL 65370
11 EX-101.DEF dwtx-20250331_def.xml EX-101.DEF 231877
12 EX-101.LAB dwtx-20250331_lab.xml EX-101.LAB 479151
13 EX-101.PRE dwtx-20250331_pre.xml EX-101.PRE 385953
84 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20250331x10q_htm.xml XML 987326
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39811 | Film No.: 25928985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)